AI-powered digital therapeutics for sleep health and insomnia
About zBrain
Our Mission
zBrain enhances global health by improving sleep through AI-driven, neuroscience-based digital therapeutics. We make evidence-based sleep care accessible to all, anytime and anywhere.
Adaptive CBT-I Development
We develop adaptive CBT-I by combining cognitive models of insomnia with reinforcement learning. Our AI continuously personalizes treatment to maximize effectiveness.
Personalized Therapy
Using AI and digital phenotyping, we tailor interventions to each individual’s sleep patterns and needs. This enables better engagement, outcomes, and long-term well-being.
Clinical Validation
Our therapeutics undergo rigorous clinical trials for Korean FDA approval by 2027. We ensure safety, efficacy, and real-world impact in clinical practice.
Solutions
Adaptive Digital CBT-I
AI-tailored therapy that adapts to each user's cognitive and behavioral patterns.Optimized based on individual sleep opportunity, need, and ability.
At-Home PSG Integration
AI-based assessment of sleep health driven by sleep-wake behavior and biosignal (Sleep Health Indicator – Sleep Hi), paired with personalized sleep improvement (Sleep Promoter – Sleep Pro)
TENS Device for Insomnia
Combined with transcutaneous electrical stimulation solution currently in clinical trials. Korea FDA submission is expected by 2026.
Clinical Strategy
Ybrain Collaboration
Ongoing collaboration with neurotechnology leader Ybrain, integrating: